Drugs Made In America Acquisition reported total assets of $146.90M and total liabilities of $154.31M for the quarter ended Jun 2026, down 36.9% year over year. This balance sheet covers 6 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Current Assets | ||||||
| Cash & EquivalentsCash & Equiv. | 0.00M | 923.00 | 822.00 | 717.00 | 0.01M | 0.02M |
| Prepaid Assets | 0.00M | 0.07M | 0.05M | 0.03M | 0.01M | 0.05M |
| Current Assets | 0.00M | 0.07M | 0.05M | 0.03M | 0.01M | 0.07M |
| Non-Current Assets | ||||||
| Long-Term Investments | 232.74M | 235.16M | 237.60M | 239.91M | 146.83M | |
| Other Non-Current Assets | 0.55M | |||||
| Non-Current Assets | 0.55M | 232.74M | 235.16M | 237.60M | 239.91M | 146.83M |
| Assets | 0.55M | 232.81M | 235.21M | 237.63M | 239.92M | 146.90M |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payables | 0.08M | 0.00M | 0.08M | 0.22M | 0.25M | |
| Notes Payables | 0.66M | 0.06M | 0.35M | |||
| Payables | 0.74M | 0.06M | 0.00M | 0.08M | 0.22M | 0.60M |
| Accumulated Expenses | 0.08M | 0.13M | 0.15M | 0.30M | 0.01M | |
| Total Current Liabilities | 0.80M | 0.35M | 0.30M | 0.46M | 0.38M | 2.94M |
| Non-Current Liabilities | ||||||
| Non-Current Deffered Revenue | 6.90M | 6.90M | 6.90M | |||
| Preferred Stock Liabilities | 232.74M | 235.16M | 237.60M | 239.91M | 145.17M | |
| Other Non-Current Liabilities | 6.90M | 6.90M | 6.19M | |||
| Total Non-Current Liabilities | 238.06M | 6.90M | 6.19M | |||
| Total Liabilities | 0.80M | 239.98M | 242.36M | 244.96M | 247.18M | 154.31M |
| Shareholder's Equity | ||||||
| Total Debt | 0.66M | 0.06M | 0.35M | |||
| Common Equity | -0.24M | -7.18M | -7.15M | -7.33M | -7.26M | -7.41M |
| Liabilities and Shareholders Equity | 0.55M | 232.81M | 235.21M | 237.63M | 239.92M | 146.90M |
| Retained Earnings | -0.28M | -6.33M | -6.46M | -6.72M | -7.27M | -7.41M |
Pull Drugs Made In America Acquisition's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=DMAA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "DMAA", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=DMAA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();